EnMed MicroAnalytics

Curated by Signal

Developer of lead and heavy metals screening solution

Life Sciences Technologyenmedmicroanalytics.com

Overview

EnMed MicroAnalytics has developed a screening solution to detect heavy metals in newborns and pregnant women. The proprietary EEvCard is a screening solution used to detect lead and other heavy metals that causes physical and mental damage in the babies. The solution tests the blood sample to detect the blood-metal levels in newborn babies, young children, and pregnant women.

Key facts

Founded: 2016
Headquarters: Charleston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Neurotron
Developing neuro electrodiagnostic devices
Life Sciences TechnologyTrenton, United States
HighRes Biosolutions
Provider of dynamic scheduling software, and lab automation instruments
Life Sciences TechnologyHesperia, United States
Health Heritage
Clinical decision support for personalized risk assessment for major inheritable cancers.
Life Sciences TechnologyChicago, United States

About EnMed MicroAnalytics

What does EnMed MicroAnalytics do?

EnMed MicroAnalytics has developed a screening solution to detect heavy metals in newborns and pregnant women.

Where is EnMed MicroAnalytics headquartered?

EnMed MicroAnalytics is headquartered in Charleston, United States.

When was EnMed MicroAnalytics founded?

EnMed MicroAnalytics was founded in 2016.

Which sector is EnMed MicroAnalytics in?

EnMed MicroAnalytics operates in Life Sciences Technology.

Who are EnMed MicroAnalytics's competitors?

Companies similar to EnMed MicroAnalytics include Neurotron, HighRes Biosolutions, and Health Heritage.